UCSF has received a $100 million donation for its memory and aging center, a gift that doctors at the dementia care clinic ...

Richard Oakley of the Alzheimer's Society spoke to Newsweek about why now is an "exciting time" in the battle against the ...

The treatment, lecanemab, has already been approved in some other countries, including the U.S., the U.K., Japan, Mexico and ...

Alzheimer's disease is a progressive neurological disorder characterised by memory loss and cognitive decline, caused by ...

Funded by the Alzheimer's Society, a group of scientists are racing against time to track the changes in the brain that leads ...

Scientists at CSIRO, Australia's national science agency, have identified simpler and less invasive methods to improve ...

Early detection of Alzheimer's disease has come a step closer thanks to a new measurement method developed by chemists at ...

One in five people will develop dementia in their lifetime, but there are early signs that there could be a cure or treatment for the disease in the future.

While the causes of MCI, Alzheimer's and dementia remain unknown, doctors are concentrating on the buildup of amyloid protein ...

On Real Possibilities with AARP Michigan, associate professor of translational neuroscience Dr. Scott Counts from Michigan ...

The drug, lecanemab, was approved by Health Canada this week. It is the first treatment available in Canada to focus on the ...

Disrupted sleep patterns in Alzheimer’s disease may be more than a symptom—they could be a driving force. Researchers at Washington University found that the brain’s circadian rhythms are thrown off ...